Screening and Support for Youth (SASY)
Launched by CAMBRIDGE HEALTH ALLIANCE · May 14, 2024
Trial Information
Current as of July 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Screening and Support for Youth (SASY) trial is a study aimed at improving mental health support for teens aged 12 to 17, especially those from diverse backgrounds in the Denver area. The goal is to adapt existing programs to better meet the needs of young people from different races, ethnicities, and languages. This means the trial will explore effective ways to reach out to these teens and provide them with the mental health support they need.
To be eligible for this study, participants must be between 12 and 17 years old. Unfortunately, younger kids or those older than 17 cannot join. While the trial is not currently recruiting participants, those who join can expect to be part of a program that focuses on understanding and addressing mental health challenges in their communities. This trial is important because it seeks to reduce differences in mental health care, ensuring that all teens have access to the support they deserve.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 12 to 17 year old teens
- Exclusion Criteria:
- • younger than 12 or older than 17
About Cambridge Health Alliance
Cambridge Health Alliance (CHA) is a prominent healthcare system in Massachusetts, dedicated to providing high-quality, community-centered health services. As a clinical trial sponsor, CHA leverages its robust research infrastructure and commitment to innovation to advance medical knowledge and improve patient outcomes. With a focus on diverse populations, CHA conducts clinical trials across various therapeutic areas, ensuring that research is inclusive and reflective of the community it serves. The organization is committed to ethical standards and regulatory compliance, fostering collaboration among healthcare professionals, researchers, and participants to drive advancements in clinical care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Laura Podewils
Principal Investigator
Denver Health and Hospital Authority
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported